Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet B, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau-Fischer B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M.
Henriquez S, et al. Among authors: zerbit j.
Blood. 2022 Feb 10;139(6):942-946. doi: 10.1182/blood.2021013714.
Blood. 2022.
PMID: 34905598
Free PMC article.
No abstract available.